Le premier médicament conçu par IA commercialisé d’ici 2030 ? Premier médicament entièrement conçu par une IA, le rentosertib devrait bientôt entrer en phase 3 d’essais cliniques et pourrait être commercialisé d’ici quelques années

#Santé Le premier médicament conçu par une #IA pourrait être commercialisé d’ici 2030
👉Le #rentosertib devrait bientôt entrer en phase 3 d’essais cliniques
www.20minutes.fr/sante/419581...

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial - Nature Medicine Preliminary results from a phase 2a trial involving 71 patients suggest that a new agent, discovered and designed with artificial intelligence assistance, is safe and effective for the treatment of id...

Super proud of our new paper out in Nature Medicine @natureportfolio.nature.com: Phase IIa trial of AI-discovered #Rentosertib in ptns w/ IPF. Absolute privilege working w/ amazing Insilico clinical & science teams & collabs. Many thnx to ptns for their trust!

www.nature.com/articles/s41...

Insilico Medicine's Groundbreaking Publication on Rentosertib and AI-Driven Drug Development Insilico Medicine has made significant strides in drug development with Rentosertib for IPF, utilizing innovative AI techniques. Promising results were published.

Insilico Medicine's Groundbreaking Publication on Rentosertib and AI-Driven Drug Development #United_States #Cambridge #Insilico_Medicine #AI_Drug_Discovery #Rentosertib